Description
Tracks minimal residual disease (MRD) in cancer patients by sequencing tumor mutations and monitoring allele frequencies using next-generation sequencing (NGS).
This lab test includes home sample collection via a provided kit or by a clinician, and you'll receive a comprehensive physical health report with your results.